Soft Tissue Repair Market Analysis

Soft Tissue Repair Market Analysis

To get key market trends

  Download Free Sample

 

Based on product, the tissue patch/matrix segment held the majority market share in 2021 and was valued at more than USD 6,779 million owing to soaring demand and rising awareness regarding the benefits offered by tissue patch/matrix in soft tissue repair procedures. As per the U.S. FDA, using hernia matrix may enhance a patient’s outcome because the repair procedure and recovery may take less time compared to other treatment options. Further, some studies have shown that surgeries using tissue matrix led to fewer hernia recurrences.
 

Market players are also emphasizing on the designing of novel soft tissue patches to meet the needs of the most demanding soft tissue repairs with minimal complications. Thus, the preference for innovative tissue patches is significantly surging attributable to a smart design that offers greater suture retention, inert material that minimizes foreign body response, etc.
 

Based on application, the orthopedic segment held a substantial market share in 2021 and is expected to reach USD 5,776 million by 2030 due to the rising demand and increasing awareness related to extensive advantages delivered by the tissue repair products in the management of multiple orthopedic conditions. The advent of novel technologies comprising biological meshes, bioprinting, and bio fabrication to treat such disease conditions is anticipated to boost the segment revenue.
 

With the augmented activity of an elderly population, the product demand is also expected to upsurge in the coming years. According to the International Osteoporosis Foundation, the total number of hip fractures is expected to reach 6.26 million by 2050.  As a result, a number of individuals suffering from orthopedic diseases and the availability of high-quality products are projected to boost the industry growth positively in the coming years.
 

 

Based on end-use, the hospitals segment held a dominant market share in 2021 and is estimated to witness substantial growth to reach more than USD 10,439 million by 2030 owing to the soaring use of novel tissue repair products in hospital settings delivering rapid and reliable outcomes is estimated to surge the patient preference for these healthcare facilities. The availability of a broad spectrum of technologically advanced tissue fixation devices for performing these surgical procedures with proven accuracy will drive product preference in hospitals.
 

Growing admissions with chronic soft tissue injuries and the growing popularity of minimally invasive therapies along with the accessibility to board-certified healthcare professionals are some other variables that are augmenting the segmental growth positively. Furthermore, the rising disease burden in developed economies with enhanced healthcare infrastructure is projected to stimulate the procedure rate at hospitals. As a result, accessibility to an effective treatment coupled with the rising admissions with chronic soft tissue injuries will boost patient visits to hospitals.
 

 

U.S. dominated the North America market with a significant market share in 2021 and is anticipated to expand at a considerable pace to reach more than USD 7,242 million by 2030. The significant market share is attributable to several factors such as the presence of major business players, an increase in the demand for tissue repair products, etc. The presence of prominent players such as Zimmer Biomet, Stryker Corporation, and Arthrex among others is engaged in new product development & commercialization that facilitates the industrial expansion in the region.
 

Soft tissue repair products comprising tissue patches and xenografts play a crucial role in plastic surgeries. According to the American Society of Plastic Surgeons (ASPS) procedural statistics, in 2020, around 1.8 million surgical cosmetic procedures and 15.9 million minimally invasive cosmetic procedures were performed in the U.S. Moreover, ongoing advancements in product development, growing healthcare expenditure, and the availability of well-equipped surgical care facilities are stimulating the product demand positively.